1. Acupuncture for chronic persistent asthma based on the theory of Meridian-viscera Association: study protocol for a multi-center randomized controlled trial in China.
- Author
-
Cheng, Shirui, Dong, Xiaohui, Lan, Lei, He, Zhaoxuan, Yu, Siyi, Yang, Yi, Zhang, Chuantao, Chen, Mei, Yang, Jun, Chu, Haoran, Liu, Yalan, Wang, Menglin, Huang, Qingsong, and Zeng, Fang
- Subjects
- *
RANDOMIZED controlled trials , *ACUPUNCTURE , *CLINICAL trial registries , *EXPIRATORY flow , *ASTHMA , *ASTHMA diagnosis , *ASTHMA treatment , *RESEARCH , *CLINICAL trials , *QI (Chinese philosophy) , *HUMAN body , *MEDICAL cooperation , *TREATMENT effectiveness , *ACUPUNCTURE points , *QUALITY of life , *RESEARCH funding - Abstract
Background: Acupuncture is effective in symptom and quality of life improvement of chronic asthma, but the efficacy differences between different acupoints are uncertain. In terms of the theory of Meridian-viscera Association, the study aims to investigate the different effectiveness between acupoints in Lung meridian and the acupoints in Heart meridian, so as to provide the evidence to develop a better prescription of the acupuncture treatment of chronic persistent asthma.Methods: This study is a multicentral randomized controlled trial. A total of 68 chronic persistent asthma patients will be randomly allocated into two groups: the Lung meridian group and the Heart meridian group. This trial will include a 2-week baseline period, a 4-week treatment period with 12 sessions' acupuncture, and an 8-week follow-up period. The primary outcome is the Asthma Quality of Life Questionnaire (AQLQ). Secondary outcomes are the Asthma Control Test (ACT), Peak Expiratory Flow (PEF), and Forced Expiratory Volume in 1 s (FEV1). The AQLQ and ACT will be collected at baseline, week 4, week 8, and week 12 after randomization. PEF, FEV1, the Self-rating Anxiety Scale (SAS), and the Self-rating Depression Scale (SDS) will be assessed at baseline and week 4.Discussion: The results will provide evidence for acupuncture prescription selection and the clinical efficacy improvement. The results of this trial will also be used to determine whether or not a full definitive trial will go ahead, which will further confirm the theory of Meridian-viscera Association.Trial Registration: Chinese Clinical Trial Registry ( http://www.chictr.org.cn/showproj.aspx?proj=43803 ) ChiCTR1900027284. Registered on 7 November 2019. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF